Two US lawmakers are questioning whether Heritage Pharmaceuticals misled them in response to a 2014 congressional inquiry about the rising price a common antibiotic, after 20 US states this week accused the company of price fixing. In a Dec. 16 letter to Heritage seen by Reuters, Maryland Democratic Rep. Elijah Cummings and Vermont Independent Sen. Bernie Sanders said they feared the company was “disingenuous at best” in October, 2014, when it told them it had not seen any significant price increases for its doxycycline hyclate product.
Category: Doxycycline (generic), Vibramycin, Doryx
How a Boozy Golf Round Hiked Drug Prices
… market protection, either through patents or something else,” said Dana Goldman, director of the Schaeffer Center for Health Policy and Economics at the University of Southern California. Executives from Heritage, a New Jersey company described as …